|
Market Cap (17-May) $95,239,352 (971st) |
Close (9-Dec) $1.04 |
Volume (9-Dec) 0 |
Shortsold (3-Dec) 50,000 (0.05%) (513th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.144 |
BD1 released this announcement to the ASX on 7 July 2021, 9:46. The announcement is marked as price sensitive, and is 25 page(s) in length and 1.38MB in size.
You can view all announcements from BD1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, BD1 was 0.001% short sold according to ASIC data. It was ranked the 643rd most shorted stock on the ASX. It is now ranked as the 513th most shorted stock on the ASX with 0.054% of total shares short sold as of the latest reported data (03 December 2021).
| Other Recent Announcements from BD1 | |
|---|---|
| BARD1 Changes its Name to INOVIQ | 8 December 2021, 8:58 |
| Cleansing Notice - Issued of Four Shares - Resolution 5 AGM | 7 December 2021, 12:12 |
| Application for quotation of securities - BD1 | 7 December 2021, 12:06 |
| BARD1 Investor Presentation | 7 July 2021, 9:46 |
| BARD1 Autoantibody Test Results for Ovarian Cancer Published | 29 June 2021, 8:21 |
| SubB2M Breast Cancer Test Manuscript Submitted | 25 June 2021, 8:22 |
| Update on Legal Proceedings | 4 June 2021, 10:20 |
You must be logged in to post a reply.
BARD1 Life Sciences 